Gevo Strengthens Operational Leadership Amid Ongoing Growth and Succession Planning
Globe Newswire (Mon, 5-Jan 9:00 AM ET)
Globe Newswire (Thu, 18-Dec 9:00 AM ET)
Globe Newswire (Mon, 15-Dec 9:00 AM ET)
Gevo Reports Third Quarter 2025 Financial Results
Globe Newswire (Mon, 10-Nov 4:01 PM ET)
Globe Newswire (Wed, 5-Nov 9:00 AM ET)
Globe Newswire (Tue, 4-Nov 9:00 AM ET)
Globe Newswire (Mon, 3-Nov 9:00 AM ET)
Gevo to Report Third Quarter 2025 Financial Results on November 10, 2025
Globe Newswire (Mon, 20-Oct 4:56 PM ET)
Market Chameleon (Tue, 23-Sep 7:30 AM ET)
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
Gevo trades on the NASDAQ stock market under the symbol GEVO.
As of January 12, 2026, GEVO stock price climbed to $2.00 with 716,385 million shares trading.
GEVO has a beta of 1.25, meaning it tends to be more sensitive to market movements. GEVO has a correlation of 0.09 to the broad based SPY ETF.
GEVO has a market cap of $484.62 million. This is considered a Small Cap stock.
Last quarter Gevo reported $43 million in Revenue and -$.03 earnings per share. This beat revenue expectation by $6 million and exceeded earnings estimates by $.02.
In the last 3 years, GEVO traded as high as $3.39 and as low as $.48.
The top ETF exchange traded funds that GEVO belongs to (by Net Assets): VTI, PBW, IWM, XOP, VXF.
GEVO has underperformed the market in the last year with a price return of -14.2% while the SPY ETF gained +18.9%. GEVO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -11.9% and -3.4%, respectively, while the SPY returned +3.7% and +0.5%, respectively.
GEVO support price is $1.92 and resistance is $2.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEVO shares will trade within this expected range on the day.